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INTRODUCTION 
1.1 HYPERTENSION 
   Hypertension is a strong independent risk factor for coronary and 
cerebrovascular diseases, as well as for heart failure, atrial fibrillation and chronic 
renal failure[1], thus substantially contributing to the global burden of disease.  
Hypertension is a common disease that is defined simply as persistently 
elevated arterial blood pressure (BP). Increasing awareness and diagnosis of 
hypertension and improving control of BP with appropriate treatment are considered 
critical Public health initiatives to reduce cardiovascular morbidity and mortality. 
Moreover, it is well known that reducing blood pressure (BP) in hypertensive 
patients is associated with a significant reduction in the rate of cardiovascular 
complications and decline in renal function[2,3]. 
           The 7th report of Joint National Committee on prevention, detection, 
evaluation,  and treatment of hypertension, defined hypertension as systolic blood 
pressure (SBP) of 140mmHg or more (or) diastolic blood pressure (DBP) of 90mmHg 
or more[4]. 
1.1.1 Classification of Hypertension: 
 It is a heterogeneous medical condition. In most patients it results from 
unknown pathophysiologic etiology (essential or primary hypertension). While this 
form of hypertension cannot be cured, it can be controlled. A small percentage of 
patients have a specific cause of their hypertension (secondary hypertension). It is 
defined simply as persistently elevated arterial BP. 
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Table. 1 Classification of Blood Pressure 
Classification Systolic BP(mmHg) Diastolic BP(mmHg) 
Normal  Less than 120  Less than 80 
Prehypertension 120-139  80-89 
Stage 1 hypertension  140-159  90-99 
Stage 2 hypertension  ≥ 160  ≥100 
 
1.1.2 ETIOLOGICAL CLASSIFICATION 
In most patients it results from unknown pathophysiologic etiology (essential 
or primary hypertension). While this form of hypertension cannot be cured, it can be 
controlled. A small percentage of patients have a specific cause of their hypertension 
(secondary hypertension). There are many potential secondary causes that are either 
concurrent medical conditions or endogenously induced. If the cause of secondary 
hypertension can be identified, hypertension in these patients potentially can be cured. 
1.1.2.1 Primary hypertension 
Essential (also known as primary) hypertension is high blood pressure for 
which a specific cause is unknown. The majority (90-95%) of hypertension cases falls 
into this category.  
Factors implicated in primary hypertension include: 
• Age 
• Genetics 
• Environment 
• Weight 
• Race. 
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Over 90% of individuals with hypertension have essential hypertension 
(primary hypertension)[5]. Numerous mechanisms have been identified that may 
contribute to the pathogenesis of this form of hypertension, so identifying the exact 
underlying abnormality is not possible. Hypertension often runs in families, indicating 
that genetic factors may play an important role in the development of essential 
hypertension. Data suggest that there are monogenic and polygenic forms of BP 
dysregulation that may be responsible for essential hypertension. Many of these 
genetic traits feature genes that affect sodium balance, but genetic mutations altering 
urinary kallikrein excretion, nitric oxide release, aldosterone excretion, other adrenal 
steroids, and angiotensinogen are also documented. 
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1.1.2.2 Secondary hypertension 
Secondary hypertension is high blood pressure that is a symptom of an 
identified medical problem, such as kidney disease. If the medical problem is fixed, 
the high blood pressures will decrease[6]. 
Causes of secondary hypertension include: 
• Renal disease 
• Pregnancy 
• Hormonal factors 
• Drug-induced factors (e.g. oral contraceptives, corticosteroids). 
About 10% of patients have secondary hypertension, where either a comorbid 
disease or a drug is responsible for elevating BP [5]. In most of these cases, renal 
dysfunction resulting from chronic kidney disease or renovascular disease is the most 
common secondary cause[8]. Certain drugs, either directly or indirectly, can cause 
hypertension or exacerbate hypertension by increasing BP.. Some of these agents are 
herbal products. Although these are not technically drugs, they have been identified as 
causes of elevated BP and secondary hypertension. When a secondary cause is 
identified, removing the offending agent or treating/correcting the underlying 
comorbid condition should be the first step in management. 
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Table: 2 Secondary Causes of Hypertension 
Disease Drugs associated with hypertension in humans 
 
Chronic kidney disease 
Cushing’s syndrome 
Coarctation of the aorta 
 
Obstructive sleep apnea 
Parathyroid disease 
Pheochromocytoma 
Primary aldosteronism 
Renovascular disease 
Thyroid disease 
Prescription drugs 
Corticosteroids, ACTH 
Estrogens (usually oral contraceptives with high 
estrogenic activity) 
Nonsteroidal anti-inflammatory drugs, COX-2 
inhibitors 
Phenylpropanolamine and analogues 
Cyclosporine and tacrolimus 
Erythropoetin 
Sibutramine 
Antidepressants (especially venlafaxine), 
bromocriptine, buspirone, 
carbamazepine, clozapine, desfulrane, ketamine, 
metoclopramide 
Clonidine/ β-blocker combination 
Pheochromocytoma: β-blocker without α-blocker 
first 
Other Natural Products 
Cocaine and cocaine withdrawal 
Ma huang, “herbal ecstasy”, other 
phenylpropanolamine analogues 
Nicotine and withdrawal, anabolic steroids, narcotic 
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withdrawal, 
methylphenidate, phencyclidine, ketamine, 
ergotamine and other 
ergot-containing herbal products, St. John’s wort 
Food Substances 
Sodium 
Ethanol 
Licorice 
Tyramine-containing foods if taking a monoamine 
oxidase inhibitor 
Chemical Elements and Other Industrial 
Chemicals 
Lead, mercury, thallium and other heavy metals, 
lithium 
 
1.1.3 EPIDEMIOLOGY 
           Recent data from the World Health Organization (WHO) indicate that nearly 
one billion people in the world are suffering from hypertension. Forecasts suggest 
that, with the aging of the population, this number could reach 1.5 billion by 2025[1]. 
Reviews of studies on hypertension epidemiology in India have shown high 
prevalence in both urban and rural areas[7-8]. 
Worldwide, high blood pressure (HBP) is estimated to cause 7.1 million 
deaths, about 13 percent of the global fatality total. Across world health organization 
(WHO) regions, research indicates that about 62 percent of strokes and 49 percent of 
heart attacks are caused by HBP[9]. 
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Increasing awareness and diagnosis of hypertension and improving control of 
BP with appropriate treatment are considered critical Public health initiatives to 
reduce cardiovascular morbidity and mortality.  
The “Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure” provides a new 
guideline for hypertension prevention and management. According to JNC – 7 
guidelines in persons older than 50 years, systolic blood pressure greater than 140 
mmHg is a much more important cardiovascular disease (CVD) risk factor than 
diastolic blood pressure[5]. 
The WHO estimates that 600 million people with HBP are at risk of heart 
attack, stroke and cardiac failure. Worldwide, Indo-Asian people are among the 
populations at highest risk for cardiovascular disease[10]. 
 Evidence also suggests that associations between body mass index (BMI), 
percentage of body fat and chronic disease may increase the risk of cardiovascular 
diseases. Because of the observed differences between populations, the International 
Association for the Study of Obesity and the International Obesity Task Force have 
suggested lower BMI cutoff values for the definitions of overweight (23.0–24.9 
kg/m2) and obesity (25.0 kg/m2 or greater) in Asian populations[11].  
Dubey VD [12] carried out one of the earliest study in India (1954), 
documented 4% prevalence of hypertension (criteria:>160/95) amongst. During 1984-
87 Gopinath and Chadha
 
et al., [10] reported the prevalence of hypertension  (criteria: 
>160/90) to be 11% among males and 12% among females in the urban areas and 4% 
and 3% respectively in rural areas. Another two studies carried out in rural areas[11]
 
(1994-95) demonstrated 4.5% prevalence of hypertension (JNC V criteria) while 
urban areas had a higher prevalence of 45% during 1996-97[18].
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1.1.4 SIGNS AND SYMPTOMS 
• Bluish lips and skin (cyanosis) 
• Blurred vision 
• Chest pain or pressure 
• Confusion 
• Dizziness 
• Fainting spells (syncope) 
• Fatigue / decreased energy 
• Headache 
• Palpitations (a strong feeling of a fast heartbeat) 
• Papilledema (swelling of the optic disc) 
• Racing pulse 
• Edema (swelling in the ankles or legs) 
• Shortness of breath, at rest and /or during periods of exercise[19]. 
1.1.4.1 Risk Factors for Hypertension 
Known modifiable risk factors for hypertension are: 
• Obesity 
• Excessive intakes of salt, fat (especially saturated fat), and calories 
• Inadequate physical activity 
• Uncontrolled hyperglycaemic states 
• High alcohol consumption 
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• Tobacco use 
• Low potassium intake 
• Sleep apnoea 
•
 Psychosocial stress is often implicated but difficult to measure 
 
1.1.5 DIAGNOSIS 
Essential hypertension is usually asymptomatic. The primary physical finding 
is elevated BP. The diagnosis of hypertension cannot be made based on one elevated 
BP measurement. The average of two or more measurements taken during two or 
more clinical encounters should be used to diagnose hypertension [5]. Thereafter, this 
BP average can be used to establish a diagnosis and then to classify the stage of 
hypertension present in the patient. 
1.1.5.1 Measuring blood pressure 
Sphygmomanometer 
Indirect measurement of BP using a sphygmomanometer is a common routine 
medical screening tool that should be conducted at every health care encounter[6]. The 
appropriate procedure to measure BP has been described by the American Heart 
Association (AHA)[13]. It is imperative that the measurement equipment (inflation 
cuff, stethoscope, manometer) meet certain national standards. These standards use 
criteria to ensure maximum quality and precision with measurement. 
Ambulatory Blood Pressure Monitoring 
 Ambulatory blood pressure monitoring (ABPM) provides information about 
BP during daily activities and sleep[14].These devices use either a microphone to 
measure Korotkoff sounds or a cuff that senses arterial waves using oscillometric  
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techniques. Twenty-four hour BP monitoring provides multiple readings during all of 
a patient’s activities. 
Ambulatory BP values are usually lower than clinic readings. Awake 
hypertensive individuals have an average BP of >135/85 mmHg, and during sleep, 
>120/75 mmHg. ABPM also provides a measure of the percentage of BP readings that 
are elevated, the overall BP load, and the extent of BP fall during sleep. In addition, it 
was reported recently that ABPM patients whose 24-hour BP exceeded 135/85 mmHg 
were nearly twice as likely to have a cardiovascular disease[15].  
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Laboratory and Other Diagnostic Tests 
 The routine laboratory tests recommended before initiation of therapy 
include: electrocardiogram; urinalysis; blood glucose and hematocrit; serum 
potassium; creatinine (or corresponding estimated glomerular filtration rate) and 
calcium[16], lipid profile (9-12 hours fasting) which includes high-density lipoprotein 
cholesterol, low-density lipoprotein cholesterol and triglycerides. Optional tests 
include measurement of urinary albumin excretion or albumin/creatinine ratio. More 
extensive investigation for identifiable causes is not generally indicated unless BP 
control is not achieved. 
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Table. 3 SCREENING tests for identifiable hypertension 
DIAGNOSIS DIAGNOSTIC TEST 
Chronic kidney disease 
Estimated Glomerular Filtration 
Rate 
Coarctation of the aorta CT angiography 
Cushing’s syndrome and other 
glucocorticoid excess states 
including chronic steroid therapy 
History; dexamethasone 
suppression test 
 
Drug induced/related History; drug screening 
Pheochromocytoma 
24-hour urinary metanephrine and 
normetanephrine 
Primary aldosteronism and other 
mineralocorticoid 
specific measurements of other 
mineralocorticoids 
24-hour urinary aldosterone level or 
excess states 
 
Renovascular hypertension 
Doppler flow study; magnetic 
resonance angiography 
Sleep apnea Sleep study with O2 saturation 
Thyroid/parathyroid disease 
Thyroid stimulating hormone(TSH); 
serum Parathyroid hormone( PTH) 
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1.1.6 PATHOPHYSIOLOGY [6,17] 
A clear understanding of arterial BP and regulation is needed to manage 
hypertension appropriately and to understand antihypertensive drug therapy 
mechanistically. Multiple factors that control BP are potential contributing 
components in the development of hypertension. These include malfunctions in either 
humoral (i.e., the renin-angiotensin-aldosterone system [RAAS]) or vasodepressor 
mechanisms, abnormal neuronal mechanisms, defects in peripheral autoregulation, 
and disturbances in sodium, calcium, and natriuretic hormone. Many of these factors 
are cumulatively affected by the multifaceted RAAS, which ultimately regulates 
arterial BP. 
 1.1.6.1 Potential mechanisms of pathogenesis 
Blood pressure is the mathematical product of cardiac output and peripheral 
resistance. Increased blood pressure can result from increased cardiac output and/or 
increased total peripheral resistance. 
 
AME-apparent mineralocorticoid excess; CNS-central nervous system; GRA-
glucocorticoid-remediable aldosteronism. 
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Increased cardiac output Increased peripheral resistance 
Increased cardiac preload: 
 Increased fluid volume from 
excess sodium intake or renal  
sodium retention (from reduced 
number of nephrons or decreased 
glomerular filtration) 
Venous constriction: 
 Excess stimulation of the RAAS 
 Sympathetic nervous system 
overactivity 
Functional vascular constriction: 
 Excess stimulation of the RAAS 
 Sympathetic nervous system 
overactivity 
 Genetic alterations of cell 
membranes 
 Endothelial-derived factors 
Structural vascular hypertrophy: 
 Excess stimulation of the RAAS 
 Sympathetic nervous system 
overactivity 
 Genetic alterations of cell 
membranes 
 Endothelial-derived factors 
 Hyperinsulinemia resulting from 
obesity or  the metabolic syndrome 
 
 1.1.6.2 Humoral mechanisms 
 Several humoral abnormalities may be involved in the development of 
essential hypertension. These abnormalities may involve the the renin-angiotensin-
aldosterone system, natriuretic hormone and hyperinsulinemia. 
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The renin-angiotensin-aldosterone system (RAAS) 
 The RAAS is a complex endogenous system that is involved with most 
regulatory components of arterial BP. Activation and regulation are governed 
primarily by the kidney. The RAAS regulates sodium, potassium, and fluid balance. 
Therefore, this system significantly influences vascular tone and sympathetic nervous 
system activity and is the most influential contributor to the homeostatic regulation of 
BP. Renin is an enzyme that is stored in the juxtaglomerular cells, which are located 
in the afferent arterioles of the kidney. The release of renin is modulated by several 
factors: intrarenal factors (e.g., renal perfusion pressure, catecholamines, and 
angiotensin II) and extrarenal factors (e.g., sodium, chloride, and potassium). 
 Renin catalyzes the conversion of angiotensinogen to angiotensin I in the 
blood. Angiotensin I is then converted to angiotensin II by angiotensin-converting 
enzyme (ACE). After binding to specific receptors (classified as either AT1 or AT2 
subtypes), angiotensin II exerts biologic effects in several tissues. The AT1 receptor is 
located in brain, kidney, myocardium, peripheral vasculature, and the adrenal glands. 
These receptors mediate most responses that are critical to cardiovascular and kidney 
function. The AT2 receptor is located in adrenal medullary tissue, uterus, and brain. 
Stimulation of the AT2 receptor does not influence BP regulation. Circulating 
angiotensin II can elevate BP through pressor and volume effects. The pressor effects 
include direct vasoconstriction, stimulation of catecholamine release from the adrenal 
medulla, and centrally mediated increases in sympathetic nervous system activity. 
Angiotensin II also stimulates aldosterone synthesis from the adrenal cortex. This 
leads to sodium and water reabsorption that increases plasma volume, total peripheral 
resistance, and ultimately, BP. 
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Release of rennin 
(stimulated by renal ischaemia, depressed sodium concentration, decreased 
potassium intake, fluid depletion) 
 
 
    Angiotensinogen 
 
 
     Angiotensin I  
                                 (decapeptide) 
 
     
    Angiotensin II             vasoconstriction                  
                                (octapeptide)                
                                                                      salt & water retension 
 
         aldosterone  
                                          
   Angiotensin III 
 
 
 
Inactive fragments           angiotensin IV 
 
 
Blood 
pressure 
Plasma 
volume 
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Natriuretic hormone 
Natriuretic hormone inhibits sodium and potassium ATPase and thus 
interferes with sodium transport across cell membranes. Inherited defects in the 
kidney’s ability to eliminate sodium can cause an increased blood volume. A 
compensatory increase in the concentration of circulating natriuretic hormone 
theoretically could increase urinary excretion of sodium and water. However, this 
same hormone is also thought to block the active transport of sodium out of arteriolar 
smooth muscle cells. The increased intracellular concentration of sodium ultimately 
would increase vascular tone and BP. 
Insulin resistance and hyperinsulinemia 
Increased insulin concentrations may lead to hypertension because of 
increased renal sodium retention and enhanced sympathetic nervous system activity. 
Moreover, insulin has growth hormone–like actions that can induce hypertrophy of 
vascular smooth muscle cells. Insulin also may elevate BP by increasing intracellular 
calcium, which leads to increased vascular resistance. The exact mechanism by which 
insulin resistance and hyperinsulinemia occur in hypertension is unknown. However, 
this association is strong because many of the criteria used to define this population 
(elevated blood pressure, obesity, dyslipidemia, and elevated blood glucose) are often 
present in hypertensive patients[6]. 
Neuronal regulation   
 The central and autonomic nervous systems are intricately involved in the 
regulation of arterial BP. A number of receptors that either enhance or inhibit 
norepinephrine release are located on the presynaptic surface of sympathetic 
terminals. The α and β presynaptic receptors play a role in negative and positive 
feedback to the norepinephrine containing vesicles located near the neuronal ending. 
Stimulation of presynaptic α-receptors (α2) exerts a negative inhibition on 
norepinephrine release. Stimulation of presynaptic β-receptors facilitates further 
release of norepinephrine. Sympathetic neuronal fibers located on the surface of 
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effector cells innervate the α- and β-receptors. Stimulation of postsynaptic α-
receptors (α1) on arterioles and venules results in vasoconstriction. There are two 
types of postsynaptic β-receptors, β1 and β2. Both are present in all tissue innervated 
by the sympathetic nervous system. However, in some tissues, β1-receptors 
predominate, and in other tissues, β2-receptors predominate. Stimulation of β1-
receptors in the heart results in an increase in heart rate and contractility, whereas 
stimulation of β2-receptors in the arterioles and venules causes vasodilation. 
Peripheral autoregulatory components 
Abnormalities in renal or tissue autoregulatory systems could cause 
hypertension. It is possible that a renal defect in sodium excretion may develop first, 
which can then cause resetting of tissue autoregulatory processes, resulting in a higher 
arterial BP. The kidney usually maintains normal BP through a volume-pressure–
adaptive mechanism. When BP drops, the kidneys respond by increasing retention of 
sodium and water. These changes lead to plasma volume expansion, which increases 
BP. Conversely, when BP rises above normal, renal sodium and water excretion are 
increased to reduce plasma volume and cardiac output. This ultimately will maintain 
homeostatic BP conditions. 
Vascular endothelial mechanisms 
Vascular endothelium and smooth muscle play important roles in regulating 
blood vessel tone and BP. These regulating functions are mediated through vasoactive 
substances that are synthesized by endothelial cells. It has been postulated that a 
deficiency in the local synthesis of vasodialating substances (e.g., prostacyclin and 
bradykinin) or excess vasoconstricting substances (e.g., angiotensin II and endothelin 
I) contribute to essential hypertension, atherosclerosis, and other diseases. Nitric 
oxide is produced in the endothelium, relaxes the vascular epithelium, and is a very 
potent vasodilator. The nitric oxide system is an important regulator of arterial BP. 
Hypertensive patients may have an intrinsic deficiency in nitric oxide release, 
resulting in inadequate vasodilatation. Although the exact role of nitric oxide in 
hypertension is unclear, it may be a pharmacologic target in the future. 
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Electrolytes and other chemicals 
Epidemiologic and clinical data have associated excess sodium intake with 
hypertension. Population-based studies indicate that high-salt diets are associated with 
a high prevalence of stroke and hypertension. Conversely, low-salt diets are 
associated with a low prevalence of hypertension. Clinical studies have shown 
consistently that dietary sodium restriction lowers BP in many (but not all) patients 
with elevated BP. 
         Altered calcium homeostasis also may play an important role in the 
pathogenesis of hypertension. A lack of dietary calcium hypothetically can disturb the 
balance between intracellular and extracellular calcium, resulting in an increased 
intracellular calcium concentration. This imbalance can alter vascular smooth muscle 
function by increasing peripheral vascular resistance. 
          In the case of potassium, Potassium depletion may increase peripheral vascular 
resistance, but the clinical significance of small serum potassium concentration 
changes is unclear. Furthermore, data demonstrating reduced cardiovascular risk with 
dietary potassium supplementation are very limited. 
 1.1.7 TREATMENT 
1.1.7.1 GOALS of therapy  
  The ultimate goal of antihypertensive therapy is to reduce cardiovascular and 
renal morbidity and mortality.  most persons with hypertension, especially those >50 
years of age, the primary focus should be on attaining the systolic blood pressure 
(SBP) goal. Treating systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) to target <140/90 mmHg is associated with a decrease in cardiovascular 
disease (CVD) complications. In patients with hypertension and diabetes or renal 
disease, the BP goal is <130/80 mmHg[4]. 
 
 
A PROSPECTIVE STUDY OF PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS IN  A TERTIARY CARE HOSPITAL 
Master of Pharmacy 25 J.K.K. Nattraja College of Pharmacy 
 
 
 
1.1.7.2 General approach to treatment 
               Patients should be placed on both lifestyle modifications and drug therapy 
concurrently. Lifestyle modifications alone are not considered adequate for patients 
with hypertension or hypertensive patients with diabetes and chronic kidney disease. 
           The choice of initial drug therapy depends on the degree of BP elevation and 
the presence of compelling indications. Most patients with stage 1 hypertension 
should be treated initially with a thiazide-type diuretic. For most patients with more 
severe BP elevation (stage 2 hypertension), combination drug therapy, with one of the 
agents preferably being a thiazide type-diuretic, is recommended. 
1.1.7.3 Non pharmacological therapy 
Life style modification: 
All patients with prehypertension and hypertension should be prescribed 
lifestyle modifications. These approaches are recommended by the JNC7 [5] and 
provide small to moderate reductions in SBP. Aside from lowering BP in patients 
with known hypertension, lifestyle modification can decrease the progression to 
hypertension in patients with prehypertension BP values[18]. In a number of 
hypertensive patients with relatively good BP control while on single antihypertensive 
drug therapy, sodium reduction and weight loss may allow withdrawal of drug 
therapy [19,20]. 
 A sensible dietary program is one that is designed to reduce weight gradually 
for overweight and obese patients and one that restricts sodium intake with only 
moderate alcohol consumption. Successful implementation of dietary lifestyle 
modifications by clinicians requires aggressive promotion through reasonable patient 
education, encouragement, and continued reinforcement. Patients may better 
understand the rationale for dietary intervention in hypertension if they are provided 
the following observations and facts: 
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1. Hypertension is two to three times more prevalent in overweight as compared 
with lean persons. 
2. Over 60% of hypertensive persons are overweight. 
3. Weight loss, even as little as 10 pounds, can decrease BP significantly in 
hypertensive overweight individuals [21]. 
4. Abdominal obesity is associated with the metabolic syndrome, which is a 
precursor to hypertension and insulin-resistance syndrome that may progress 
to type 2 diabetes, dyslipidemia, and ultimately, cardiovascular disease[22]. 
5. Diets rich in fruits and vegetables and low in saturated fat have been shown to 
lower BP in hypertensive individuals [23,24]. 
6. Although some hypertensive patients are not salt-sensitive, most people 
experience some degree of SBP reduction with sodium restriction[6,25]. 
A controlled diet plan is needed that is rich in fruits, vegetables, and low-fat 
dairy products with a reduced content of saturated and total fat. The recommended 
restriction is less than 2.4 g (100 mEq) sodium per day. Patients should be aware of 
the multiple sources of dietary sodium (e.g., processed meats, soups, and table salt) so 
that they may follow this restriction. Excessive alcohol use can either cause or worsen 
hypertension. Hence, Alcohol intake should be limited. Carefully designed programs 
of physical activity can lower BP. Regular aerobic exercise for at least 30 minutes a 
day most days of the week is ideal for most patients. 
1.1.7.4 Pharmacological Therapy: 
 There are 9 classes of anti hypertensive drugs. Diuretics, β-blockers, ACE 
inhibitors, angiotensin II receptor blockers, and calcium channel blockers are 
considered primary antihypertensive agents.  
These agents, either alone or in combination, should be used to treat the 
majority of hypertensive patients.  
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More than two-thirds of hypertensive individuals cannot be controlled on one 
drug and will require two or more antihypertensive agents selected from different 
drug classes.  
Several of these classes (i.e., diuretics, β-blockers, and calcium channel 
blockers) have subclasses with significant differences in mechanism of action, clinical 
use., α-Blockers, central α2-agonists, adrenergic inhibitors, and vasodilators are 
considered alternative drug classes.. 
According to JNC7 guidelines thiazide-type diuretics is preferred whenever 
possible as first-line therapy for most patients [5]. This recommendation is specifically 
for those without compelling indications. However, diuretics are also useful agents in 
hypertensive patients with compelling indications, but they are not always the first 
agent recommended. 
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Table.4 Primary antihypertensive agents 
Class Subclass Drug 
Usual Dose  
Range, mg/day 
Diuretics 
Thiazides 
Chlorthalidone 6.25–25 
Hydrochlorothiazide 12.5–50 
Indapamide 1.25–2.5 
Metolazone 0.5 
Loop diuretics 
Loops Bumetanide 0.5–4 
Furosemide 20–80 
Torsemide 5 
Potassium sparing 
Amiloride 5–10 
Amiloride/ 
Hydrochlorothiazide 
 
5–10/50–100 
 
Triamterene 50–100 
Triamterene/ 
Hydrochlorothiazide 
37.5–75/25–50 
Aldosterone 
Antagonists 
Eplerenone 50–100 
Spironolactone 25–50 
Spironolactone/ 
Hydrochlorothiazide 
25–50/25–50 
Angiotensin converting enzyme 
inhibitors 
Benazepril 10–40 
Captopril 12.5–150 
Enalapril 5–40 
Fosinopril 10–40 
Lisinopri 10–40 
Moexipril 7.5–30 
Perindopril 4–16 
Quinapril 10–80 
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Ramipril 2.5–10 
Trandolapril 1–4 
Angiotensin II receptor Blockers 
Candesartan 8–32 
Eprosartan 600–800 
Irbesartan 150–300 
Losartan 50–100 
Olmesartan 20–40 
Telmisartan 20–80 
Valsartan 80–320 
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β-Blockers 
Cardioselective 
Atenolol 25–100 
Betaxolol 5–20 
Bisoprolol 2.5–10 
Metoprolol 50–200 
Nebivolol 2.5-5 
Nonselective 
Nadolol 40–120 
Propranolol 80–320 
Timolol 10–40 
Intrinsic 
sympathomimetic 
activity 
Acebutolol 200–800 
Carteolol 2.5–10 
Penbutolol 10–40 
Pindolol 10–60 
Mixed α- and 
β-blockers 
Carvedilol 12.5–50 
Labetolol 200–800 
Calcium channel 
Blockers 
Dihydropyridines 
Amlodipine 2.5–10 
Felodipine 5–20 
Isradipine 5–10 
Nicardipine 60–120 
Nifedipine 30–90 
Nisoldipine 10–40 
Non-
Dihydropyridines 
Diltiazem 180–360 
Verapamil 180–480 
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Table.5 Alternative antihypertensive agents 
Class Drug 
Usual Dose  
Range, 
mg/day 
α1-Blockers 
Doxazosin 1–8 
Prazosin 2–20 
Terazosin 1–20 
Central α2-agonists 
Clonidine 0.1–0.8 
Methyldopa 250–1000 
Peripheral adrenergic antagonist Reserpine 0.05–0.25 
Direct arterial vasodilators 
Minoxidil 10–40 
Hydralazine 20–100 
 
1.1.7.4.1 Individual Antihypertensive Agents [4,21,26] 
Diuretics 
Diuretics, preferably a thiazide, are first-line agents for most patients with 
hypertension. Moreover, when combination therapy is needed in hypertension to 
control BP, a diuretic is recommended as one of the agents used [5].  Four subclasses of 
diuretics are used in the treatment of hypertension: thiazides, loop diuretics, 
potassium-sparing agents, and aldosterone antagonists Thiazide diuretics have 
additional actions that may further explain their antihypertensive effects. Thiazides 
mobilize sodium and water from arteriolar walls. This effect would lessen the amount 
of physical encroachment on the lumen of the vessel created by excessive 
accumulation of intracellular fluid. As the diameter of the lumen relaxes and 
increases, there is less resistance to the flow of blood, and peripheral vascular 
resistance drops further. Thiazides also are postulated to cause direct relaxation of 
vascular smooth muscle. 
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Angiotensin-converting enzyme inhibitors (ACEI) 
ACE inhibitors are considered second-line therapy to diuretics in most patients 
with hypertension [5]. ACE inhibitors have many roles for patients with hypertension 
and coexisting conditions. ACE facilitates the production of angiotensin II, which has 
a major role in the regulation of arterial BP. ACE, is distributed in many tissues and is 
present in several different cell types, but its principal location is in endothelial cells. 
Therefore, the major site for angiotensin II production is in the blood vessels, not the 
kidney. ACE inhibitors block the conversion of angiotensin I to angiotensin II. This 
latter substance is a potent vasoconstrictor that also stimulates aldosterone secretion. 
ACE inhibitors also block the degradation of bradykinin and stimulate the synthesis of 
other vasodilating substances, including prostaglandin and prostacyclin. The 
observation that ACE inhibitors lower BP in patients with normal plasma rennin 
activity suggests that bradykinin and perhaps tissue production of ACE are important 
in hypertension. Increased bradykinin enhances the BP-lowering effects of ACE 
inhibitors. 
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Angiotensin II receptor blockers 
Angiotensin II is generated by two enzymatic pathways: the RAAS, which 
involves ACE, and an alternative pathway that uses other enzymes such as chymases. 
ACE inhibitors inhibit only the effects of angiotensin II produced through the RAAS, 
whereas ARBs inhibit angiotensin II from all pathways. It is unclear how these 
differences affect tissue concentrations of ACE. Because of these differences, ACE 
inhibitors only partially block the effects of angiotensin II. ARBs directly block the 
angiotensin II type 1 (AT1) receptor that mediates the known effects of angiotensin II 
in humans: vasoconstriction, aldosterone release, sympathetic activation, antidiuretic 
hormone release, and constriction of the efferent arterioles of the glomerulus. They do 
not block the angiotensin II type 2 (AT2) receptor. Therefore, beneficial effects of 
AT2 receptor stimulation (i.e., vasodilation, tissue repair, and inhibition of cell 
growth) remain intact when ARBs are used. Unlike ACE inhibitors, ARBs do not 
block the breakdown of bradykinin. Therefore, some of the beneficial effects of 
bradykinin such as vasodilation (which can enhance BP lowering), regression of 
myocyte hypertrophy and fibrosis, and increased levels of tissue plasminogen 
activator are not present with ARB therapy. 
Calcium channel blockers (CCB) 
CCBs are not first-line agents but are very effective antihypertensive agents, 
especially in African-American patients. They have compelling indications in high 
coronary disease risk and in diabetes. However, with these compelling indications, 
they are in addition to or in replacement of other antihypertensive drug classes. Some 
data indicated that dihydropyridines may not provide as much protection against 
cardiac events when compared with “conventional” therapy (diuretics and β-blockers) 
or ACE inhibitors in uncomplicated hypertension [27]. Contraction of cardiac and 
smooth muscle cells requires an increase in free intracellular calcium concentrations 
from the extracellular fluid. When cardiac or vascular smooth muscle is stimulated, 
voltage-sensitive channels in the cell membrane are opened, allowing calcium to enter 
the cells. The influx of extracellular calcium into the cell releases stored calcium from 
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the sarcoplasmic reticulum. As intracellular free calcium concentration increases, it 
binds to a protein, calmodulin, which then activates myosin kinase, enabling myosin 
to interact with actin to induce contraction. CCBs work by inhibiting influx of 
calcium across the cell membrane. There are two types of voltage-gated calcium 
channels: a high-voltage channel (L-type) and a low-voltage channel (T-type). 
Currently available CCBs only block the L-type channel, which leads to coronary and 
peripheral vasodilation. 
β-blockers 
β-Blockers have been used in several large outcome trials in hypertension.  
Several mechanisms of action have been proposed for β-adrenoreceptor blockers (β-
blockers), but none of them alone has been shown to be associated consistently with a 
reduction in arterial BP. β-Blockers have negative chronotropic and inotropic cardiac 
effects that reduce cardiac output, which explains some of the antihypertensive effect. 
However, cardiac output falls equally in patients treated with β-blockers regardless of 
BP lowering. β-Blockers that possess a greater affinity for β1-receptors than β2-
receptors are cardioselective. Both β1- and β2-adrenoceptors are distributed 
throughout the body, but they concentrate differently in certain organs and tissues. 
There is a preponderance of β1- receptors in the heart and kidney and a 
preponderance of β2-receptors in the lungs, liver, pancreas, and arteriolar smooth 
muscle. β1-Receptor stimulation increases heart rate, contractility, and renin release. 
β2-Receptor stimulation results in bronchodilation and vasodilation. Cardioselective 
β-blockers are less likely to provoke bronchospasm and vasoconstriction. 
α1-Blockers 
They work in the peripheral vasculature and inhibit the uptake of 
catecholamines in smooth muscle cells, resulting in vasodilation and BP lowering. 
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Central α2-agonists 
These agents lower BP primarily by stimulating α2-adrenergic receptors in the 
brain. This stimulation reduces sympathetic outflow from the vasomotor center in the 
brain and increases vagal tone. It is also believed that peripheral stimulation of 
presynaptic α2-receptors may further reduce sympathetic tone. Reduced sympathetic 
activity, together with enhanced parasympathetic activity, can decrease heart rate, 
cardiac output, total peripheral resistance, plasma renin activity, and baroreceptor 
reflexes. 
1.1.7.4.2 COMBINATION THERAPY: 
Choice / selection of combination therapy [JNC VII guidelines] 
According to algorithm for the treatment of hypertension in JNC VII 
additional drugs can add until goal blood pressure is achieved. 
According to JNC VII majority of diabetic patients will require two or more 
drugs to achieve BP control. 
According to JNC VII guideline a diuretic is recommended for majority of 
hypertensive patients especially in decrease glomerular filtration rate or in heart 
failure. 
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 Table: 5 choice of drug combination 
 
ARB 
 
Diuretic
s 
β-
Blockers 
ACEI CCB 
Central 
sympatholytics 
ARB          
Diuretics           
β-Blockers        
ACEI          
CCB         
Central 
sympatholytic 
       
 
CCB:  Calcium Channel Blockers             ARB:  Angiotensin II Receptor Blockers   
 ACEI:  Angiotensin converting enzyme inhibitors 
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Table -6: Mechanism of action of combined drug class: 
Combinations Mechanisms 
 
ARB-Diuretic 
ARBs cause the 
antagonism of angiotensin 
II at the 
vascular and myocardial 
level by direct AT-1 
receptor 
blockade 
Thiazide diuretic blocks 
sodium chloride 
reabsorption at the distal 
convoluted tubule 
 
 
β-Adrenoreceptor 
Antagonist-Diuretic 
The β-adrenoreceptor 
blocker inhibits activation 
by 
direct suppression of renin 
release, inhibit β- 
adrenergic sympathetic 
stimulation decreasing 
myocardial contractility 
and heart rate 
 
 
Diuretics as above 
 
 
ACEI-Diuretic 
ACEI cause the removal of 
the angiotensin II effect 
(vasoconstriction, 
stimulation of aldosterone 
secretion) and 
enhancement of kinin-
mediated 
vasodilation 
 
Diuretics as above 
 
 The calcium antagonists 
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ACEI-CCB ACEI as above de-crease vascular 
resistance by vascular 
smooth muscle 
relaxation 
ARB-CCB ARBs as above CCBs as Above 
ACE-ARB Inhibitors ACEI as above ARBs as above 
 
Centrally Acting Agents-
Diuretic 
Clonidine acts by 
decreasing sympathetic 
outflow by 
stimulating pre synaptic 
α2-adrenoceptors in the 
vasomotor centre of the 
CNS. 
 
Diuretics as above 
Disease processes affected by anti-hypertensive drugs:  
• Diabetes – Beta-blockers and thiazide diuretics may make glycemic control 
difficult.  ACE inhibitors can protect the kidney.  
• Coronary Artery Disease – Beta-blockers offer a mortality benefit (in general).  
Short-acting calcium channel blockers can worsen ischemia.  
• Congestive Heart Failure (compensated vs. un-compensated) – Beta-blockers 
offer a mortality benefit as do ACE inhibitors. Beta-blockers should not be used 
in uncompensated CHF. 
• Hyperlipidemia – Beta-blockers and thiazide diuretics may affect lipid profile 
unfavorably.  
• COPD/Asthma – Beta-blockers need to be used with caution.  
• Peripheral Vascular Disease – Beta-blockers need to be used with discretion. 
• Renal Artery Stenosis (bilateral vs. unilateral) – ACE inhibitor or ARB’s are 
relatively contraindicated. 
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• Cardiac Conduction Defects – Beta-blockers, diltiazem and verapamil can 
exacerbate conduction defects.  
• Benign Prostatic Hypertrophy – Alpha-1 blockers can provide symptomatic 
improvement.  
• Depression – Beta-blockers may exacerbate.  
• Raynaud’s Syndrome – Beta-blockers may exacerbate.  
• Renal Failure – ACE inhibitors may cause a reduction in renal performance  
• Pregnancy – ACE inhibitors and ARB’s are contraindicated.  
• Aortic Stenosis – Vasodilators need to be introduced with caution.  
• Hyperuricemia (Gout) – Thiazide diuretics may increase uric acid levels. 
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 REVIEW OF LITERATURE 
  Tiwari28 et al., (2004) conducted a study about drug prescribing trend of 
antihypertensive agents at Panjab University Health Centre in India. The study was 
conducted in order to establish the drug-prescribing trend of anti-hypertensive agents. 
The information was collected from prescription of outpatient department. World 
Health Organisation-based prescription-auditing proforma was used for data 
collection. This study revealed that most of the male patients were on monotherapy. 
In the monotherapy category, four classes of drugs were used. These were calcium 
channel blockers, beta-blockers, ACE inhibitors and diuretics. Among monotherapy 
drugs, calcium channel blockers were prescribed most whereas diuretics were least 
used. Overall, 57.8 percent patients were treated with a single anti-hypertensive drug 
and 42.2 percent were treated with anti-hypertensive drug combinations. The study 
highlights certain shortcomings in the existing prescribing practice. There is a 
considerable scope for improvement, particularly the under-utilization of diuretics in 
the present prescribing pattern of antihypertensive drugs. 
 Akici29 et al., (2007)  conducted a study on Antihypertensive drug utilization at 
health centers in a district of Istanbul. Objective of the study was to evaluate 
antihypertensive drug utilization in hypertension, because irrational use of 
antihypertensives has considerable clinical and economical consequences. A total of 
297 hypertensive patients who accepted to participate in the study were evaluated by a 
face-to-face questionnaire and a copy of their prescriptions were collected for 
prescription analysis. They concluded that that General Practitioners (GPs) working 
at primary healthcare centers were rational in terms of antihypertensive drug choice. 
However, they poorly applied rational pharmacotherapy principles such as (a) writing 
a “good’’ prescription which is easily readable by the pharmacist and the patient and 
that contains full essential information; (b) a medical examination of the patient to 
assess her/his current clinical condition; and (c) taking care of not prescribing drugs 
with potential interaction like antihypertensives and NSAIDs together. 
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Adeel Aslam30 et al., (2007) conducted a comparative study on 
antihypertensive therapy using single drug versus multiple drugs in pregnancy 
induced hypertension. The objective of the study was to assess the stress response in 
severe pregnancy induced hypertensive patients on different drug regimen during 
preoperative and postoperative period. 40 patients of severe pregnancy induced 
hypertensives were induced in this study. 20 patients were placed on a single standard 
antihypertensive i.e. alpha methyldopa and 20 were put on a combination of alpha 
methyldopa with long acting nifedipine or amlodipine. Both these groups underwent 
caesarean section. The stress response in both these groups was carefully analyzed 
and compared with a special note on any untoward effect on the mother or fetus. The 
results from this trial clearly demonstrated that patients on combined drug therapy 
showed better stress response during perioperative and postoperative period. Thus the 
authors concluded that in severe PIH patients undergoing caesarean section good feto-
maternal outcome was obtained on combination antihypertensive drug therapy as 
compared to patients receiving single anti-hypertensive drug. 
White31 et al., (2010) conducted a study to investigate the management of 
hypertension in patients with diabetes mellitus, living in a rural setting southeastern 
Australia. Patients with either diagnosed hypertension or high blood pressure who 
attended the clinic were included in their study. The awareness and control of 
hypertension was compared between patients with and without diabetes mellitus. A 
total of 449 patients with hypertension were analyzed. One hundred twenty-one 
(26.9%) had hypertension and diabetes mellitus, and 328 (73.1%) had hypertension 
without diabetes mellitus. Hypertension awareness (61.2% versus 36.9%, P=0.014) 
and control (17.4% versus 7.0%, P=0.040) were significantly better in the 
hypertensive patients with diabetes mellitus than in the hypertensive patients without 
diabetes mellitus. Antihypertensive medication use was also significantly higher in 
patients with diabetes mellitus than in patients without diabetes mellitus (one 
antihypertensive medication, 41.3% versus 25.0%, P=0.045).The authors concluded 
that Awareness and control of hypertension were suboptimal in the patients in the 
present study. Diabetes mellitus, however, was associated with both higher awareness 
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and better control of hypertension than having hypertension alone. This may be 
partially due to a higher use of antihypertensive medications by patients with diabetes 
mellitus. 
Balakeshwa32 et al., (2008) studied the prescribing pattern of antihypertensive 
therapy in Medical Wards at a Teaching Hospital. It was conducted in the General 
medicine unit of JSS Medical College Hospital, Mysore. This study was intended to 
systematically assess the prescribing pattern of antihypertensive in patients with mild 
to moderate essential hypertension. It was a prospective and observational study 
conducted over a period of eight months. Primary hypertensive patients of either sex 
aged greater than or equal to18 years and fulfill JNC-7 criteria were enrolled. All 
enrolled patients were followed until their discharge. They concluded as beta-blockers 
and diuretics were widely used as mono and combination therapy in treating mild to 
moderate primary hypertension. 
 Garcia33 et al., (2004) conducted a study on use of Antihypertensive drugs in 
Spain. The data was obtained from the data base of the Spanish ministry of Health. 
This study was aimed to describe the pattern of use in Spain from 1995 to 2001, its 
compliance with guidelines, and its economic impact. Aim of the study was the 
impact of angiotensin II receptor antagonists on the consumption of the drugs from 
other therapeutic subgroups. Information on drug utilization was obtained from the 
ECOM database of the Spanish Ministry of Health, which records the number of 
packages charged to the National Health System. They concluded that the 
consumption of antihypertensive drugs in Spain has increased remarkably in last 7 
years. Likewise cost also increased proportionately, although the contributions of 
different therapeutic subgroups have been unequal. The impact of angiotensin II 
receptor antagonists has been considerable, both on consumption and on costs. 
 Etuk34 et al., (2008) Conducted prescription pattern of anti-hypertensive drugs 
in a tertiary health institution in Nigeria. This study examined the pattern of 
physicians’ prescription of antihypertensive drugs and its possible effects on blood 
pressure control as well as physician’s compliance with recommended guidelines. 
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Records of 145 patients aged 17-91 (mean: 52.6 ± 14.6) years, with male to female 
ratio of 1:1.2 were randomly selected. Information on antihypertensive prescriptions 
was recorded. Blood pressure control was defined as systolic and diastolic blood 
pressure less than 140 mm Hg and 90mmHg, respectively. Information collected from 
antihypertensive prescription. Their results are consistent with the previously 
observed benefits of antihypertensive combination therapy, and demonstrate an 
apparent higher efficacy of calcium channel blocker monotherapy than diuretic 
monotherapy in blood pressure lowering in the study population. Major limitations of 
this work include its retrosective nature and the inability to determine the actual 
patients’ adherence to therapy. 
Pang-Hsiang35 et al., (2008) conducted study of Antihypertensive medication 
prescription patterns and time trends for newly-diagnosed uncomplicated 
hypertension patients. It was conducted in Taiwan. The aims of this study were to 
determine the prescription patterns and time trends for antihypertensive medication in 
newly-diagnosed cases of uncomplicated hypertension in Taiwan and to compare 
these with current clinical guidelines. A total of 6,536 newly-diagnosed patients with 
uncomplicated hypertension, aged >30 years, were identified from the representative 
200,000-person sample in the computerized reimbursement database of the National 
Health Insurance in Taiwan. According to their study the    prescription patterns 
varied by age, gender and clinical facilities, with mono-therapies being found to be 
dominant in the first year, albeit declining over time and calcium channel blockers 
and beta-blockers were the most frequently prescribed antihypertensive drugs, either 
alone or in combinations. These findings indicate the existence of a gap between 
current clinical practice and the desired goal of cost-effectiveness in antihypertensive 
treatment in Taiwan, which should be corrected.  
Jeschke36 et al., (2009) conducted a study on Evaluation of prescribing 
patterns in a German network of CAM physicians for the treatment of patients with 
hypertension. The study was aimed to investigate hypertension treatment strategies 
among physicians specialized in complementary and alternative medicine (CAM) in 
Germany by analysing prescribing patterns and comparing these to the current 
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treatment guidelines issued by the German Hypertension Society. In this prospective, 
multicentre observational study, which included 25 primary care physicians 
specialized in CAM treatment, prescriptions and diagnoses were analysed for each 
consecutive hypertensive patient using routine electronic data. Data analysis was 
performed using univariate statistical tests (Chi square test, Cochran-Armitage trend 
test). Multiple logistic regression was used to determine factors associated with 
antihypertensive medication. Most patients were treated with conventional 
antihypertensive monotherapies. Beta-blockers were the most commonly prescribed 
monotherapy, followed by ACE inhibitors. Combination treatment usually consisted 
of two antihypertensive drugs administered either as separate agents or as a 
coformulation. The most common combination was a diuretic plus an ACE inhibitor. 
Patient gender, age, and comorbidities significantly influenced which treatment was 
prescribed. The study concluded as  large majority of antihypertensive treatments 
prescribed by CAM physicians in the present study complied with the current German 
Hypertension Society treatment guidelines. Deviations from the guidelines were 
observed in one of every seven patients receiving some form of CAM treatment. 
 Chantal37 et al., (2001) conducted a study on Antihypertensive Drug Therapy 
in Saskatchewan. The aim of the study was to examine the distribution and 
determinants of patterns of use of antihypertensive agents in the first 5 years of 
hypertension treatment in Saskatchewan. Patterns of use and modifications to therapy 
were derived from a careful examination of medication use in a cohort of 19501 
subjects aged 40 to 79 years, without recognized cardiac disease and initiating therapy 
with an angiotensin -converting enzyme inhibitor, a calcium antagonist, or a b-blocker 
in Saskatchewan between 1990 and 1993. Angiotensin-converting enzyme inhibitors, 
followed by calcium antagonists and b-blockers, were the most commonly prescribed 
agents to initiate treatment in our study population. Patients with diabetes were less 
likely to be dispensed a b-blocker, as were younger and female patients. Previous 
visits to a cardiologist decreased the likelihood of receiving combination therapy or 
angiotensin converting enzyme inhibitors but increased that of using calcium 
antagonists. Erratic drug-taking behaviors were observed in this Saskatchewan 
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population. In addition, initial drug use does not seem to be in accordance with the 
stepped-care approach to hypertension therapy recommended in the Canadian 
guidelines. 
Rajeshwari38 et al., (2007) conducted a Drug Utilisation Study in Geriatric 
Type 2 Diabetic Patients. This study was aimed to evaluate the drug utilisation pattern 
in geriatric T2DM patients. The study was conducted for a period of 6 months (July 
2004 to January 2005) in an out-patient department of a tertiary hospital in 
Mangalore, Karnataka, India. The medical records of 64 geriatric (age >60 years) type 
2 diabetic patients attending the diabetic clinic were reviewed. Drug prescribed 
mainly for DM and hypertension were included along with other drugs used for their 
comorbidities. Along with drug regimens, demographic data, age, and gender were 
recorded. The results were analysed using descriptive statistics. In elderly patients 
with type 2 diabetes, treatment may be initiated with monotherapy, followed by early 
intervention with a combination of oral agents, including a sulphonylurea as a 
foundation insulin secretagogue in addition to a supplemental insulin sensitizer. The 
study also showed that a combination of sulphonylurea and metformin was most 
frequently prescribed. Accordingly, metformin is widely regarded as the first drug of 
choice for most patients with type 2 diabetes mellitus. The study concluded that type 
2 diabetic is a progressive and complex disorder that is difficult to treat effectively in 
the long term. The treatment pattern observed in this study corroborates with the 
accepted pattern of treatment for DM with hypertension, and/or neuropathy. 
Metformin, glimepiride, and glibenclamide are most commonly prescribed OADs. 
Enalapril and ramipril among the ACEIs and atenolol and metaprolol among the beta-
blockers are the frequently prescribed antihypertensives. 
Supratim39 et al., (2010) conducted a cross sectional prescription pattern 
study in a antihypertensive drug use in patients having comorbid diabetes in a tertiary 
care hospital manipal. This study aims at analyzing the influence of current guidelines 
on prescribing in this particular subset of patients. Hypertension and diabetes when 
present together are associated with a multitude of complications, all of which result 
in increased morbidity and mortality. This makes it vital to, not only make an early 
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detection of the disease, but also to make the best use amongst the wide array of drugs 
available for treatment. Case history of patients having hypertension along with 
diabetes was noted down from the medical records department. Drugs prescribed in 
each of these groups were noted and pattern analyzed. A total of 128 prescriptions 
were of diabetes, amongst which 19 had nephropathy and the remaining 109 did not 
have nephropathy. The authors concluded that  the CCB’s were the group of drugs 
prescribed the most in both diabetes and diabetes associated nephropathy. They were 
prescribed in 60% patients with diabetes, and 95% of those who had nephropathy. 
The ACE‐inhibitors and ARB’s were prescribed in 45% patients with diabetes and 
21% in diabetes associated nephropathy. Utilization of ACE‐ inhibitors is thus well 
below it is expected to be in both diabetes as well as diabetes associated nephropathy. 
Skliros40 et al., (2007) Conducted a study to determine hypertension 
prevalence and levels of awareness, treatment and control of hypertension among 
diabetic patients using data from the VANK (Valachioti(V), Astras(A), Nemea(N) 
and Kalavarita(K) study. The sample consisted of 221 men and women (122/99) 
diagnosed with type 2 diabetes. Semi-structured interviews were conducted with all 
participants. Controlled hypertension definition was based on having a systolic blood 
pressure (BP) of <130 mmHg and diastolic BP of <85 mmHg in subjects taking 
antihypertensive medications. The mean ± SD BP was 141.6 ± 17.4 mmHg and 81.2 ± 
9.4 mmHg for systolic and diastolic BPs, respectively. Systolic and diastolic BP was 
higher in men than in women. The overall prevalence of hypertension was 194/221 
(87.7%). In total, 34.1% of patients (66/194) were not aware of having hypertension. 
Of those who were aware of having hypertension (n = 128, 65.9%), all were treated. 
Among those treated, only 11 persons (11/194, 5.6%) had systolic BP <130 mmHg 
and diastolic BP <85 mmHg. Sixty-two (38.7%) had systolic BP <140 mmHg and 
diastolic BP <90 mmHg. The authors concluded that all of the diagnosed hypertensive 
patients (n = 128) received antihypertensive drug therapy, in only 8.6% (11/128) the 
treatment was effective (BP <130/85 mmHg). Translating our findings into clinical 
practice, there is a need for aggressive treatment of hypertension from primary care 
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physicians, as well as regular surveillance to detect developing hypertension in 
diabetic patients.  
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AIM AND OBJECTIVE 
AIM 
To study the prescribing pattern of antihypertensive drugs in a tertiary care 
hospital erode. 
OBJECTIVES 
• To study the demographic details of the study population. 
• To study the BMI and family history of hypertensive patients. 
• To determine the occupational status and dietary habits of study population. 
• To categorize the prescription pattern and identity the most commonly 
prescribed antihypertensive drugs   
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PLAN OF WORK 
The entire study was planned to be carried out for a period of 8 months.  
The proposal was designed as given below: 
• Proposal 
• Phase 1 
 Identify the scope of work 
 Literature survey 
 Study design including designing of questionnaire form 
 Approval from ethical committee. 
• Phase 2 
 Collection of patient details from patient case reports and by conducting 
direct patient interview 
• Phase 3 
 Data analysis 
 Submission of report 
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METHODOLOGY 
The study was aimed to study of prescribing pattern of antihypertive drugs.  
Study design: 
It is a Prospective observational study. 
Study site: 
The study was conducted at tertiary care hospital Erode.  
Study period: 
      8 months (From July 2016 to Feb 2017) 
Inclusion criteria: 
• Patients diagnosed with hypertension. 
• Both male and female patients will be included in the study 
• Patients above  20 years of age 
Exclusion criteria: 
• Patients who are not interested to participate in this study 
• Patients with doubtful diagnosis 
• Patients who are critically ill 
• Patients below 20 years of age 
 
 
 
 
A PROSPECTIVE STUDY OF PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS IN  A TERTIARY CARE HOSPITAL 
Master of Pharmacy 51 J.K.K. Nattraja College of Pharmacy 
 
 
 
Source of data: 
The data collects from various sources such as patient case reports and also 
through direct patient interview 
 
WORK METHODOLOGY  
Based on the inclusion and exclusion criteria the study was conducted at 
tertiary care hospital erode. 
 Details  regarding demographics, social habits like alcohol intake, drug abuse 
and smoking, food habit and family history are collected   through interviewed 
patients  
 Data about current medical condition and prescription drugs will be collected 
from patient case report and through direct patient interview. 
 The data obtained will be categorized and the current prescribing trends will 
be evaluated on basis of comparison with the standard treatment guidelines.
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Table – 1: Gender wise distribution of hypertensive patients 
Gender Number of patients (n=360) Percentage(%) of patients 
Male 196 54.44 
Female 164 45.55 
 
Figure – 1: Gender wise distribution of hypertensive patients 
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Table – 2: Age wise distribution of hypertensive patients 
Age 
(years) 
Hypertension (n=360) 
 
Percentage (%) of 
patients 
20-24 4 1.11 
25-34 18 5 
35-44 50 13.88 
45-54 82 22.77 
55-64 144 40 
65+ 62 17.22 
  
Figure – 2: Age wise distribution of hypertensive patients 
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 Table – 3: Distribution of hypertension based on body mass index ( BMI ) 
BMI category 
 
Number of patients 
(n=360) 
Percentage (%) of patients 
Under Weight (< 18.5) 55 15.27 
Normal Weight 
(18.5 – 24.9) 
88 24.44 
Over Weight  
(25 – 29.9) 
194 53.88 
Obesity ( >30) 23 6.38 
 
Figure – 3: Distribution of Hypertension based on 
Body Mass Index (BMI) 
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Table – 4: Residential area wise distribution of hypertensive patients 
Residential area Number of patients 
( n=360 ) 
Percentage (%) of patients 
Rural 91 25.27 
Urban 186 51.66 
Mixed 83 23.05 
 
Figure – 4: Residential area wise distribution of Hypertensive patients 
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Table – 5: Distribution of hypertension based on occupation 
Occupation Number of patients 
(n=360) 
Percentage (%) of patients 
Executive / Business 38 10.55 
Agriculture 72 20 
Domestic workers 15 4.16 
Services / sales 
(marketing) 
25 6.94 
Manual workers 192 53.33 
Nil 18 5 
 
Figure – 5: Distribution of Hypertension based on occupation 
 
Occupation 
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Table – 6: Distribution of hypertension based on sanitation 
Sanitation 
 
Number of patients 
(n=360) 
Percentage (%) of patients 
Noise free zone 96 26.66 
Noise pollution 264 73.33 
 
Figure – 6: Distribution of hypertension based on sanitation 
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Table – 7: Distribution of hypertension based on sleep disturbance / work stress 
Sleep disturbance / stress 
 
Number of patients 
(n=360) 
Percentage (%) of 
patients 
Normal sleep 95 26.38 
Sleep disturbance/Work 
stress 
265 73.61 
 
Figure – 7: Distribution of hypertension based on sleep disturbance / work stress 
 
A PROSPECTIVE STUDY OF PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS IN  A TERTIARY CARE HOSPITAL 
Master of Pharmacy 59 J.K.K. Nattraja College of Pharmacy 
 
 
 
Table – 8: Distribution of hypertension based on food consumption 
Food consumption 
Number of patients 
(n=360) 
Percentage (%) of patients 
Vegetarian 56 15.55 
Vegetarian & 
Non-vegetarian 
304 84.44 
 
Figure – 8: Distribution of Hypertension based on food consumption 
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Table – 9: Distribution of hypertension based on oil consumption 
Oil consumption 
Number of patients 
(n=360) 
Percentage (%) of patients 
Coconut oil 25 6.94 
Palm oil 190 52.77 
Sunflower oil 94 26.11 
Groundnut oil 51 14.16 
Soybean oil 0 0 
 
Figure – 9: Distribution of Hypertension based on oil consumption 
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Table – 10: Distribution of hypertension based on consumption of dairy products 
Dairy products 
Number of patients 
(n=360) 
Percentage (%) of patients 
Milk 30 8.33 
Coffee / tea 258 71.66 
Health drinks 56 15.55 
None 16 4.44 
 
Figure – 10: Distribution of hypertension based on consumption of dairy 
products 
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Table – 11: Distribution of hypertension based on behavioral risk factors 
Behavioral risk factors 
 
Number of patients 
(n=360) 
Percentage (%) of 
patients 
Smoking 35 9.72 
Tobacco chewing 32 8.88 
Alcohol 52 14.44 
Smoking+tobacco+alcohol 146 40.55 
OTC drugs 20 5.55 
None  75 20.83 
 
Figure – 14: Represents distribution of Hypertension based on behavioural risk 
factors 
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Table – 12: Family history of hypertensive patients 
Family relationship Number of patients 
(n=360) 
Percentage (%) of patients 
Father 153 42.5 
Mother 62 17.22 
Both 25 6.94 
Others 14 3.88 
None 106 29.44 
 
Figure – 12: Family history of hypertensive patients 
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Table – 13: History of raised blood pressure of hypertensive patients 
History of raised blood 
pressure 
Number of patients 
(n=360) 
Percentage (%) of patients 
Within Past 12 months 8 2.22 
1 to 5 years 132 36.66 
5 to 10 years 192 53.33 
More than 10 years 28 7.77 
 
Figure – 13: History of raised blood pressure 
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Table - 14: Type of therapy preferred in hypertensive patients 
 
Type of Therapy 
Number of patient 
(n=360) 
Percentage (%) of 
therapy Preferred 
Monotherapy 184 51.11 
Two drug therapy 120 33.33 
Three drug therapy 40 11.11 
Four drug therapy 16 4.44 
 
Figure – 14: Type of the therapy in hypertensive patients 
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Table – 15: Classes of antihypertensive drugs used to treat hypertensive patients  
MONOTHERAPY 
Classes of drugs 
Number of patients 
(n=184) 
Percentage (%) of drugs 
prescribed 
β-Blockers 80 43.47 
Calcium Channel Blockers (CCB) 66 35.86 
Angiotensin II Receptor Blockers 
(ARB) 
28 15.21 
Angiotensin Converting Enzyme 
Inhibitors (ACEI) 
6 3.26 
Diuretics 4 2.17 
 
CCB:  Calcium Channel Blockers             ARB:  Angiotensin II Receptor Blockers   
 ACEI:  Angiotensin converting enzyme inhibitors 
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Figure – 17: Classes of drugs in hypertensive patients for mono 
therapy 
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Table – 16: Classes of antihypertensive drugs used to treat hypertensive patients  
TWO DRUG THERAPY 
Classes of drugs Number of patients (n=120) Percentage (%) of drugs 
prescribed 
CCB + β-Blockers 46 38.33 
ARB + CCB 26 21.66 
ARB + Diuretics 22 18.33 
CCB + ACEI 9 7.5 
CCB + Diuretics 9 7.5 
β-Blockers + Diuretics 4 3.33 
  β-Blockers + ACEI 4 3.33 
 
CCB:  Calcium Channel Blockers             ARB:  Angiotensin II Receptor Blockers   
 ACEI:  Angiotensin converting enzyme inhibitors 
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Figure – 16: Classes of drugs in Combination therapy 
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Table – 17: Classes of antihypertensive drugs Used to treat hypertensive patients  
THREE DRUG THERAPY 
Classes of drugs 
 
Number of patients 
(n=40) 
Percentage (%) of drugs 
prescribed 
ARB + Diuretics + β-Blockers 12 30 
ARB + CCB + β-Blockers 10 25 
β-Blockers + CCB + Diuretics 6 15 
CCB + ACEI + β-Blockers 6 15 
ARB + Diuretics + CCB 6 15 
 
CCB:  Calcium Channel Blockers, ARB:  Angiotensin II Receptor Blockers   
 ACEI:  Angiotensin converting enzyme inhibitors 
Figure – 17: Classes of drugs in three drug therapy 
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Table – 18: Classes of antihypertensive drugs used to treat hypertensive patients  
FOUR DRUG THERAPY 
Classes of drugs Number of patients (n=16) Percentage (%) of drugs 
prescribed 
ARB + Diuretics + 
β-Blockers + CCB 
9 56.25 
CCB + ACEI + 
β-Blockers + Diuretics 
7 43.75 
 
CCB:  Calcium Channel Blockers             ARB:  Angiotensin II Receptor Blockers   
 ACEI:  Angiotensin converting enzyme inhibitors 
Figure – 18: Classes of drugs in four drug therapy 
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Table – 19: Prescribing pattern of antihypertensive drugs for hypertensive 
patients  
MONOTHERAPY 
Drugs prescribed 
Number of 
patients  (n=184) 
Percentage (%) of 
drugs prescribed 
Metoprolol 71 38.58 
Amlodipine 66 35.86 
Telmisartan 12 6.52 
Atenolol 10 5.43 
Olmesartan 8 4.34 
Losartan 8 4.34 
Enalapril 3 1.63 
Ramipril 2 1.08 
Propranolol 2 1.08 
Perindopril 1 0.54 
Furosemide 1 0.54 
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Figure – 19: Prescribing pattern of monotherapy 
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Table – 20: Prescribing pattern of antihypertensive drugs for hypertensive 
patients  
TWO DRUG THERAPY 
Drugs prescribed 
Number of patient 
(n=120) 
Percentage (%) of drugs 
prescribed 
Amlodipine+Atenolol 44 36.66 
Telmisartan+Amlodipine 39 32.5 
Telmisartan+Hydrochlorothiazide 11 9.16 
Amlodipine+ Hydrochlorothiazide 8 6.66 
Amlodipine+Lisinopril 6 5 
Losartan+Hydrochlorothiazide 3 2.5 
Olmesartan+Hydrochlorothiazide 3 2.5 
Enalapril+Amlodipine 2 1.53 
Amlodipine+Metoprolol 1 0.83 
Metoprolol+Enalapril 1 0.83 
Atenolol+Torsemide 1 0.83 
Amlodipine+Torsemide 1 0.83 
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Figure – 20: Prescribing pattern of Combination therapy 
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Table – 21: Prescribing pattern of antihypertensive drugs for hypertensive 
patients  
THREE DRUG THERAPY 
Drugs prescribed 
Number of patient 
(n=40) 
Percentage (%) of 
drugs prescribed 
Telmisartan+Hydrochlorothiazide+ 
Metoprolol 
15 37.5 
Furosemide + Amlodipine + Atenolol 8 20 
Metoprolol + Amlodipine + Enalapril 7 17.5 
Losartan + Amlodipine + 
Hydrochlorothiazide 
7 17.5 
Telmisartan + Amlodipine + 
Metoprolol 
3 7.5 
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Figure – 21: Prescribing pattern for three drug therapy 
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Table – 22: Prescribing pattern of antihypertensive drugs for hypertensive 
patients  
FOUR DRUG THERAPY 
Drugs prescribed 
Number of 
patient (n=16) 
Percentage (%) of 
drugs prescribed 
Telmisartan + 
Hydrochlorothiazide + 
Nebivolol + Amlodipine 
10 62.5 
Amlodipine + Lisinopril +  
Bisoprolol + 
Hydrochlorothiazide 
6 37.5 
 
Figure – 22: Prescribing pattern for four drug therapy 
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RESULTS AND DISCUSSION 
The present work was carried out to determine the treatment differences 
between patients having hypertension.  
Distribution of hypertension: 
Gender wise distribution 
A total of 360 patients having hypertension were analyzed, in that 196 patients 
(54.44%) were male and 164 patients (45.55%) were female (Table-1).This result was 
similar to the study conducted by Chobanian AV et al[4] also reported that male 
patients were more prone to hypertension. 
Age wise distribution: 
In this study, different age groups were observed and higher prevalence of 
occurrence of hypertension was found in the age group of 55-64 years. In that 144 
patients (40%) were hypertension, followed by age group of 45-54 were 82 patients 
(22.77%) hypertension, age group of 65 and above were 62 patients (17.22%) 
hypertension (table-2). 
There was no significant difference in the age or sex when compared to the 
groups of hypertension. Similar result was observed by White et al [31]. 
Distribution based on Body mass index (BMI): 
 From the study, it was observed that hypertensive patients (194 patients) were 
more due to overweight category (53.88%) according to body mass index(BMI) 
(Table-3). Similar results were observed by Choo V et al [11]. 
Distribution based on residential area: 
 Table- 4 revealed that patients living in urban areas (186 patients) were found 
to show higher prevalence of hypertensive (51.66%) compared to those living in rural 
areas. This result was similar to the study conducted by Chadha SL et al [10]. 
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Distribution based on occupation: 
 From the study, it was observed that hypertensive patients (192 patients) were 
more since they are manual workers (53.33%) (Table-5). Similar results were 
observed by Dubey VD et al [12]. 
Distribution based on sanitation: 
 From the study, it is observed that hypertensive patients (264 patients) were 
more due to their habitat in noisy zone (73.33%) (Table-6). Similar result were 
noticed by White et al[31] . 
Distribution based on work stress/ sleep disturbance: 
 From the study, it was observed that hypertensive patients (265 patients) were  
more due to work stress (73.61%) (Table-7). 
Distribution based on food consumption: 
 From the study, it is observed that hypertensive patients (304 patients) were 
more consumption of non-vegetarian varieties of food (84.44%) (Table-8). This result 
was similar to the study conducted by Appel LJ et al[24]. 
Distribution based on tea/coffee consumption: 
Caffeine antagonises endogenous adenosine which causes vasoconstriction, 
this increases peripheral vascular resistance leading to increased blood pressure. Milk 
and milk products reduce the level of saturated fatty acid by complimentary 
mechanism thus lowering the blood pressure. This was also reported by Srinath 
Reddy K et al[41]. 
 Table-10 revealed that patients consuming coffee / tea (258 patients) were 
found to show higher prevalence of occurrence of hypertension (71.66%) than the 
general population (Table-10). Similar results were observed by Srinath Reddy K et 
al[41].  
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Distribution based on behavioral risk factors: 
 From the study, it was observed that hypertensive patients (146 patients) were 
more due to smoking, alcohol and tobacco chewing (40.55%) (Table-11). 
 Intake of OTC drugs (NSAID drugs) becomes a behavioral risk factor and it 
leads to cause hypertension in 5.55% of patients (Table-11). Similar results were 
observed by Akici et al[29]. 
Drug prescribing pattern: 
Type of therapy: 
 In hypertension patients, monotherapy (51.11%) is mostly preferred (Table-
14), followed by combination therapy (33.33%). 
Monotherapy: 
In hypertension patients, β-blockers (43.47%) are mostly used classes in 
monotherapy (Table-15). Where in Metoprolol (38.58%) is mostly prescribed (Table-
19). This result was similar to the study conducted by Tiwari et al[28]. 
Combination therapy: 
Two drug therapy: 
 In hypertension patients, β-blockers with calcium channel blockers (CCB) 
(38.33%) are mostly used classes in two drug therapy (Table-16). Where in 
amlodipine with atenolol (36.66%) were mostly prescribed (Table-20). 
Three drug therapy: 
In hypertension patients, angiotensin receptor blockers ARB, diuretics and β-
blockers (30%) were mostly used classes in three drug therapy (Table-17). Whereas 
telmisartan, hydrochlorothiazide and metoprolol (37.50%) were  mostly prescribed 
(Table-21). This result was similar to the study conducted by Tiwari et al[28]. 
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Four drug therapy: 
In hypertension patients, angiotensin receptor blockers ARB, diuretics, β-
blockers and calcium channel blockers (CCB) (62.5%) and calcium channel blockers 
(CCB), angiotensin converting enzyme inhibitors (ACEI), β-blockers and diuretics 
(37.5%) were used classes in four drug therapy (Table-18). Whereas Telmisartan, 
Hydrochlorothiazide, Nebivolol and Amlodipine (62.5%) and Amlodipine, Lisinopril, 
Bisoprolol and Hydrochlorothiazide (37.5%) were prescribed (Table-22). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
A PROSPECTIVE STUDY OF PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS IN  A TERTIARY CARE HOSPITAL 
Master of Pharmacy 83 J.K.K. Nattraja College of Pharmacy 
 
 
 
CONCLUSION 
 The study concluded that there was no significant difference in prevalence of 
occurrence of hypertension between male and female. 
 The prevalence of hypertension was found to be more in older than in younger 
patients. 
 In the present study, overweight category peoples were more prone to 
hypertension, diabetes and other cardiovascular diseases. 
 From the socioeconomic status, those living in urban areas and noisy zone 
were found to show marked attribute to hypertension. 
 From the present study, those people who consume more of non-vegetarian 
kinds of food, excess oil and coffee/tea were more prone to hypertension. 
 In the current study, alcoholics and smokers were found to show marked 
attribute to hypertension and also those who intake OTC drugs (NSAID’s) increases 
the risk. 
 Life style modification (proper diet, regular exercise) in patients can also help 
in controlling blood pressure. 
            Anti-hypertensive drugs must be selected in such fashion that it should be safe 
and should not worsen concomitant co-morbidies diseases. 
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ANNEXURE - 1 
DATA  ENTRY  FORM 
Name of the Patient:                                                                         Date: 
Gender: Male / Female                                Place of Survey: 
Age Group:                 18 – 24             25 – 34               35 – 44   
  45 – 54             55 – 64               65+ 
Weight:  Height:  BMI:   Normal Weight 
        Underweight 
        Overweight 
        Obesity 
Residence:   Urban             Rural      Mixed 
Education:  Illiterate 
   Primary (1 – 5) 
   Secondary (6 – 10) 
   Higher Secondary (12th) 
   Degree 
Marital Status:          Married                    Never Married 
Occupation:  Executive / Business 
   Agriculture 
   Domestic 
   Services / Sales (Marketing) 
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   Manual Workers 
 Sanitation:                 Noise free zone                 Noise Pollution 
Stress :  Normal sleep                    Sleep Disturbance / work stress 
Food Consumption:              Vegetarian                   Non-vegetarian 
 Oil Consumption:   Coconut Oil  Groundnut Oil 
    Sunflower Oil  Soybean Oil  
    Palm Oil  Mustard Oil 
Dairy Consumption:              Milk 
     Coffee / tea 
     Health Drinks 
     None 
Behavioral Risk Factors:           Smoking ( Beedi / Cigarette ) 
                                                         Tobacco                         OTC drugs (NSAID’s) 
              Alcohol 
Family History of Hypertension:                Father            Mother 
                Both                Others                  None 
History of Previous Hospitalization:         Government Hospital 
              Private Hospital 
Diagnosis:              Hypertension 
 
Blood Pressure Reading:   Systolic __________ (mm/Hg) 
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                Diastolic __________ (mm/Hg) 
    
History of Raised Blood Pressure:                 Within Past 12 Months 
          1 to 5 Years 
          5 to 10 Years 
          More than 10 Years 
 
Medication Prescribed 
S.No Brand Name Generic Name Dose     Route of 
Administration 
Frequency 
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Health Professionals Advice:  Quit Smoking 
      Quit Alcohol 
      Dietary Modification 
      Reduce Salt Intake 
      Lose Weight 
      Increase Physical Activity 
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ANNEXURE – 2 
INFORMATION FOR STUDY SUBJECTS 
Dear participant, 
 I FATHIMA BEVI A student of J.K.K.NATTRAJA COLLEGE OF 
PHARMACY currently conducting a project entitled “A prospective 
study of prescribing pattern of antihypertensive drugs in a tertiary 
care hospital” for the partial fulfillment for the award of degree of 
Master of Pharmacy in Pharmacy Practice. 
As the part of project i need to collect demographic data, identify 
the prescribing pattern of antihypertensive drugs. 
I will appreciate very much if you could kindly assist me to 
collect your medical data’s. However identifiable personal data’s will 
not be disclosed. 
Thank you very much for your kind participation. 
CONSENT FORM 
I, ____________________________, have read and understand the above 
information. I have agreed to allow my data to be collected for the 
project work. 
_______________________________        
 ____________________ 
Signature of participant                                                            Date 
 
_______________________________         
Signature of translator 
A PROSPECTIVE STUDY OF PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS IN  A TERTIARY CARE HOSPITAL 
Master of Pharmacy 96 J.K.K. Nattraja College of Pharmacy 
 
 
 
ANNEXURE – 3 
• Want to paste ethics certificate here 
• Check it all header for all chapters 
• Put image for annexure 
 
 
 
 
 
  
